The Global MRD Testing Market is expanding due to rising cancer and hematological malignancy rates and advances in diagnostic tech like next-gen sequencing. Challenges include high costs limiting ...

Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focusing on the application of next ...

However, the causative organism was not identified until 1992 by molecular methods and was initially named Tropheryma ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price ...

Key cancer diagnostics market opportunities include: early detection technologies like liquid biopsy and AI imaging, ...

The field of genomic medicine has experienced tremendous progress with the advent of next-generation sequencing (NGS), which ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...